The California legislature recently introduced legislation, SB 351, that would impact private equity or hedge funds managing physician or ...
In 2024 private equity investments and strategic acquisitions drove key deals, particularly in semiconductors and life ...
The award is the second for the stadium from the state. In October, the IEDA sealed the deal on its 2021 promise to give Des ...
Key Points - - The new administration’s effort to eliminate most DEI programs extends beyond the federal government to ...
Men don’t get questioned nearly as much.” Janaki Gooty, a professor of management at the Belk College of Business at UNC ...
Through the gym, we were doing a lot of community work, naturally for the youth,” McGhee explains. “And in 2022, we decided ...
Private-equity executives entered 2025 with high hopes for a dealmaking recovery that is lifting payouts to fund investors ...
Wall Street is often blamed for reducing corporate managers’ understanding of business to a single, gameable measure of ...
Wall Street is still awaiting regulatory approval for the first full-blown private-asset ETFs, but for now opportunistic ...
With private asset ETFs still awaiting regulatory approval, opportunistic issuers are continuing to crank out products that ...
Record revenues from management fees and a brighter outlook for M&A in the year ahead helped private equity's Big Four close 2024 on a high note.
Health Affairs' Jeff Byers welcomes Senior Editor Kathleen Haddad back to the program to discuss two recent reports exploring the impacts of private equity on the US health care system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback